Arij BEDOUI

Dr. Arij BEDOUI

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
HBHanen Baccari
Hanen Baccari
ABArij BEDOUI
Arij BEDOUI
FAferiani anouar
feriani anouar
ABAmal Bouallegue
Amal Bouallegue
NSNihad Sahri
Nihad Sahri
ZAZouhaier Abbes
Zouhaier Abbes
Background/Objectives: The search for new bioactive molecules increasingly extends beyond conventional medicinal plants, highlighting the importance of exploring alternative botanical sources. Parasitic plants represent a promising but underexploited reservoir of pharmacologically relevant compounds. Cuscuta australis (CA), a parasitic species with a history of traditional use, remains poorly characterized. This study aimed to investigate its phytochemical composition and evaluate its antioxidant, anti-inflammatory, and hepatoprotective properties. Methods: The phytochemical profile of CA extract was characterized by LC-MS. Antioxidant capacity was assessed using DPPH and ABTS assays. In vivo hepatoprotection was evaluated in male rats subjected to CCl4-induced hepatotoxicity and treated orally with CA (30 or 60 mg/kg body weight). Biochemical, lipid, oxidative stress, and histological parameters were determined. Molecular docking was conducted to predict the binding of major identified compounds against selected protein targets. Results: CA significantly and dose-dependently improved biochemical and histological markers. At 60 mg/kg, ALT, AST, ALP, and bilirubin were reduced by 32%, 33%, 63%, and 51%, respectively. Lipid metabolism was improved by decreased TC, TG, and LDL-C with increased HDL-C. Antioxidant defense was enhanced through elevated CAT, SOD, and GPx activities, accompanied by reduced MDA levels. TNF-α and IL-6 decreased by 48% and 53%, respectively. Histopathology confirmed hepatoprotection and reduced fibrosis. Docking studies revealed strong binding affinities (−7.07 to −19.20 kcal/mol) for several metabolites, notably quercetin glucoside, diosmetin glucoside, caffeic acid glucoside, feruloylquinic acid, and isorhamnetin glucoside, against CYP450, IL-2, TNF-α, and IL-6. Conclusions: These findings demonstrate that C. australis is a promising source of bioactive compounds with hepatoprotective, antioxidant, antihyperlipidemic, and anti-inflammatory effects, supporting its potential as a natural therapeutic agent.

12 May 2025 in Food Bioscience
Verified
Journal Article
Closed access
ABArij BEDOUI
Arij BEDOUI
AFAnouar Feriani
Anouar Feriani
ABAmal Bouallegue
Amal Bouallegue
HBHanene Baccari
Hanene Baccari
MBMohamed Ali Borgi
Mohamed Ali Borgi
ZAZouhaier Abbes
Zouhaier Abbes

4 May 2025 in Food Bioscience
Verified
Journal Article
Closed access
INIbtissem Nafti
Ibtissem Nafti
Reham Hassan MekkyReham Hassan Mekky
Reham Hassan Mekky
ANAbir Najahi
Abir Najahi
ABArij BEDOUI
Arij BEDOUI
AAAkram Alaya
Akram Alaya
NTNizar Tlili
Nizar Tlili